BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31952997)

  • 1. A 13-gene risk score system and a nomogram survival model for predicting the prognosis of clear cell renal cell carcinoma.
    Zhang C; Wang F; Guo F; Ye C; Yang Y; Huang Y; Hou J; Tian F; Yang B
    Urol Oncol; 2020 Mar; 38(3):74.e1-74.e11. PubMed ID: 31952997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
    Zhang M; Sun L; Ru Y; Zhang S; Miao J; Guo P; Lv J; Guo F; Liu B
    Int J Mol Med; 2020 Jul; 46(1):252-264. PubMed ID: 32377703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A five-gene methylation signature predicts overall survival of patients with clear cell renal cell carcinoma.
    Jing X; Xu G; Gong Y; Li J; LingfengWu ; Zhu W; He Y; Li Z; Pan S
    J Clin Lab Anal; 2021 Dec; 35(12):e24031. PubMed ID: 34716619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
    He Z; Deng T; Duan X; Zeng G
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and verification of a nomogram for prediction of recurrence-free survival in clear cell renal cell carcinoma.
    Chen Y; Jiang S; Lu Z; Xue D; Xia L; Lu J; Wang H; Xu L; Li L; Li G
    J Cell Mol Med; 2020 Jan; 24(2):1245-1255. PubMed ID: 31782902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.
    Wang Y; Wang Y; Liu F
    Int J Mol Med; 2018 Dec; 42(6):3105-3114. PubMed ID: 30272265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial intelligence prediction model for overall survival of clear cell renal cell carcinoma based on a 21-gene molecular prognostic score system.
    Peng Q; Shen Y; Fu K; Dai Z; Jin L; Yang D; Zhu J
    Aging (Albany NY); 2021 Mar; 13(5):7361-7381. PubMed ID: 33686949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
    Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
    Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: Prognosis for Clear Cell Renal Cell Carcinoma.
    Li Q; Yang W; Lu M; Zhang R
    Med Sci Monit; 2020 Dec; 26():e927078. PubMed ID: 33296352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis prediction.
    Tai R; Leng J; Li W; Wu Y; Yang J
    BMC Urol; 2023 Sep; 23(1):147. PubMed ID: 37715154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSAT1 enhances the efficacy of the prognosis estimation nomogram model in stage-based clear cell renal cell carcinoma.
    Wang J; He X; Mi Y; Chen YQ; Li J; Wang R
    BMC Cancer; 2024 Apr; 24(1):463. PubMed ID: 38614981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
    Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
    Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of m6A-associated ferroptosis genes in renal clear cell carcinoma.
    Pang S; Zhao S; Dongye Y; Fan Y; Liu J
    Cell Biol Int; 2024 Jun; 48(6):777-794. PubMed ID: 38440906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma.
    Tang W; Cao Y; Ma X
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32633782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients.
    Li Z; Du G; Zhao R; Yang W; Li C; Huang J; Wen Z; Li H; Zhang B
    Medicine (Baltimore); 2021 Oct; 100(39):e27374. PubMed ID: 34596153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma.
    Zhao E; Bai X
    Biomed Res Int; 2020; 2020():7434737. PubMed ID: 32280701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel autophagy-related long non-coding RNAs prognostic risk score for clear cell renal cell carcinoma.
    Tang F; Tang Z; Lu Z; Cai Y; Lai Y; Mai Y; Li Z; Lu Z; Zhang J; Li Z; He Z
    BMC Urol; 2022 Dec; 22(1):203. PubMed ID: 36496360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
    Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
    J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.